why choose us

First received: October 03, 2022

Clinical Trial: A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: RSV Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults With Acute Respiratory Syncytial Virus Infection Who Are at Hig

Brief Summary: This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult subjects with confirmed RSV infection who are at high risk for complications after RSV infection.

Read more